GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M3 Inc (OTCPK:MTHRF) » Definitions » GF Value

M3 (MTHRF) GF Value : $30.32 (As of May. 01, 2024)


View and export this data going back to 2014. Start your Free Trial

What is M3 GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-01), M3's share price is $11.67. M3's GF Value is $30.32. Therefore, M3's Price-to-GF-Value for today is 0.38.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes M3 is Significantly Undervalued.


M3  (OTCPK:MTHRF) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

M3's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=11.67/30.32
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


M3 GF Value Related Terms

Thank you for viewing the detailed overview of M3's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


M3 (MTHRF) Business Description

Traded in Other Exchanges
Address
Akasaka Intercity 10th floor, 1-11-44 Akasaka, Minato-ku, Tokyo, JPN, 105-0012
M3, Inc. is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.

M3 (MTHRF) Headlines

From GuruFocus

Matthews Japan Fund Comments on M3

By Sydnee Gatewood Sydnee Gatewood 10-21-2020

M3 WAKE RESEARCH EXPANDS INTO CHARLESTON, SC

By PRNewswire 07-07-2023

Matthews Japan Fund Comments on M3

By Sydnee Gatewood 07-20-2021

Matthews Japan Fund Comments on M3

By Sydnee Gatewood Sydnee Gatewood 10-24-2019

Matthews Japan Fund Comments on M3

By Sydnee Gatewood Sydnee Gatewood 01-25-2021

Matthews Japan Fund 3rd-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 10-21-2020